Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
36.40    -0.80 (-2.15%)
Bid:
36.30
Ask:
36.88
Spread: 0.58 (1.598%)
Market Cap: £368.62m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Form 8.3 - Aston Martin Lagonda

15 Jul 2019 09:42

RNS Number : 5195F
Baillie Gifford & Co.
15 July 2019
Β 

FORMΒ 8.3

Β 

PUBLICΒ OPENINGΒ POSITIONΒ DISCLOSURE/DEALINGΒ DISCLOSUREΒ BY

AΒ PERSONΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β OR MORE

RuleΒ 8.3Β ofΒ theΒ TakeoverΒ CodeΒ (theΒ "Code")

Β 

1. KEYΒ INFORMATION

Β 

(a) Full name of discloser:

Baillie Gifford & Co

(b) Owner or controller of interests and short

positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose

relevant securities this form relates:

Use a separate form for each offeror/offeree

Aston Martin Lagonda Global Holdings Plc

(d) If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12 July 2019

(f) In addition to the company in 1(c) above, is the

discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONSΒ OFΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

IfΒ thereΒ areΒ positionsΒ orΒ rightsΒ toΒ subscribeΒ toΒ discloseΒ inΒ moreΒ thanΒ oneΒ classΒ ofΒ relevant securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ in 1(c),Β copyΒ tableΒ 2(a)Β orΒ (b)Β (as appropriate)Β for eachΒ additionalΒ classΒ of relevantΒ security.

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ inΒ theΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offeree toΒ whichΒ theΒ disclosureΒ relatesΒ followingΒ theΒ dealingΒ (ifΒ any)

Β 

Class of relevant security:

0.01p Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned

and/or controlled:

15,406,241

6.76

(2) Cash-settled derivatives:

(3) Stock-settled derivatives

(including options) and agreements to purchase/sell:

Β 

TOTAL:

15,406,241

6.76

Β 

AllΒ interestsΒ andΒ allΒ shortΒ positionsΒ shouldΒ be disclosed.

Β 

Details Β of Β any Β open Β stock-settled Β derivative Β positions Β (including Β traded Β options), Β or agreementsΒ toΒ purchaseΒ orΒ sellΒ relevantΒ securities,Β shouldΒ beΒ givenΒ onΒ aΒ Supplemental FormΒ 8Β (OpenΒ Positions).

(b) RightsΒ toΒ subscribeΒ forΒ newΒ securitiesΒ (includingΒ directors'Β andΒ otherΒ employee options)

Β 

Class of relevant security in relation to

which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. Β DEALINGSΒ (IFΒ ANY)Β BYΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

WhereΒ thereΒ have beenΒ dealingsΒ in moreΒ than oneΒ classΒ of relevantΒ securitiesΒ of theΒ offerorΒ or offeree named inΒ 1(c), copyΒ table 3(a), (b), (c)Β orΒ (d)Β (asΒ appropriate)Β forΒ each additionalΒ class ofΒ relevantΒ securityΒ dealtΒ in.

Β 

TheΒ currencyΒ ofΒ allΒ pricesΒ andΒ otherΒ monetaryΒ amountsΒ shouldΒ beΒ stated.

Β 

(a) Β PurchasesΒ andΒ sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

0.01p Ordinary

Sale

15,119

9.3012

Β 

(b) Cash-settledΒ derivativeΒ transactions

Β 

Class of

relevant security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of

reference securities

Price per

unit

Β 

(c) Stock-settledΒ derivativeΒ transactionsΒ (includingΒ options)

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Class

of relevant security

Product

description e.g. call option

Writing,

purchasing, selling, varying etc.

Number

of securities to which option relates

Exercise

price per unit

Type

e.g. American, European etc.

Expiry

date

Option

money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of

relevant security

Product

description

e.g. call option

Exercising/

exercised against

Number of

securities

Exercise price

per unit

(d) OtherΒ dealingsΒ (includingΒ subscribingΒ forΒ newΒ securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

4. OTHERΒ INFORMATION

Β 

(a) IndemnityΒ andΒ otherΒ dealingΒ arrangements

Β 

DetailsΒ ofΒ anyΒ indemnityΒ orΒ optionΒ arrangement,Β orΒ anyΒ agreementΒ orΒ understanding, formalΒ orΒ informal,Β relatingΒ toΒ relevantΒ securitiesΒ whichΒ mayΒ beΒ anΒ inducementΒ toΒ deal orΒ refrainΒ fromΒ dealingΒ enteredΒ intoΒ byΒ theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ party toΒ theΒ offerΒ orΒ anyΒ personΒ actingΒ inΒ concertΒ withΒ aΒ partyΒ toΒ theΒ offer:

IrrevocableΒ commitmentsΒ andΒ lettersΒ of intentΒ shouldΒ notΒ be included.Β IfΒ thereΒ areΒ noΒ such agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

None

Β 

Β 

Β 

(b) Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

DetailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understanding,Β formalΒ orΒ informal,Β between theΒ personΒ makingΒ theΒ disclosureΒ andΒ anyΒ otherΒ personΒ relatingΒ to:

(i)Β theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option;Β or

(ii)Β theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ which anyΒ derivativeΒ isΒ referenced:

IfΒ thereΒ areΒ noΒ suchΒ agreements,Β arrangementsΒ orΒ understandings,Β stateΒ "none"

Β 

Β 

None

Β 

Β 

(c) Attachments

Β 

IsΒ aΒ SupplementalΒ FormΒ 8 (OpenΒ Positions)Β attached? NO

Β 

Β 

Β 

Date of disclosure:

15.07.2019

Contact name:

Rachel Graham

Telephone number:

0131 275 2120

Β 

PublicΒ disclosuresΒ underΒ RuleΒ 8Β ofΒ theΒ CodeΒ mustΒ beΒ madeΒ toΒ aΒ RegulatoryΒ Information

Service.

Β 

TheΒ Panel'sΒ MarketΒ SurveillanceΒ UnitΒ isΒ availableΒ forΒ consultationΒ inΒ relationΒ toΒ theΒ Code's disclosureΒ requirementsΒ on +44Β (0)20Β 7638Β 0129.

Β 

TheΒ CodeΒ canΒ be viewedΒ onΒ the Panel'sΒ websiteΒ atΒ Β www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RETUVOWRKWABARR
Date   Source Headline
26th Jun 20269:00 amRNSYew Tree Consortium Facility closing conditions
9th Jun 202611:32 amRNSDirector/PDMR Shareholding
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.